| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 1.82 CAD | -0.06 (-3.19%) | 1.56 - 6.50 | 9.4 thousand (Above Avg) |
Market data as of 3:09PM 05/21/13. Quotes are delayed by at least 15 min.
| Open | 1.88 |
|---|---|
| Previous Close | 1.88 |
| Day's Range | 1.82 - 1.88 |
| Market Cap | 15.9M |
| Avg Volume (10 Day) | 10.0K |
| Price/Earnings (Trailing 12 Mo.) | -- |
| Earnings Per Share (Trailing 12 Mo.) | |
| Dividend Yield | No Dividend |
Nuvo Research Announces Scientific Presentation at the Annual Meeting of the American Association of Immunologists
PR Newswire - Thursday 05/16/2013 7:30 AM ET
Nuvo Research granted U.S. Patent for treatment of allergic rhinitis and allergic asthma with WF10
PR Newswire - Tuesday 05/14/2013 5:00 PM ET
Nuvo Research announces notice of Intention to Grant a European Patent for PENNSAID® 2%
PR Newswire - Thursday 05/09/2013 7:30 AM ET
Nuvo Research to Complete Share Consolidation
PR Newswire - Tuesday 05/07/2013 7:30 AM ET
Nuvo Research announces 2013 First Quarter Results
PR Newswire - Wednesday 05/01/2013 5:00 PM ET
Nuvo Research Announces European Launch of Pliaglis® by Galderma
Business Wire - Tuesday 04/23/2013 7:45 AM ET
Nuvo Research announces European launch of Pliaglis® by Galderma
PR Newswire - Tuesday 04/23/2013 7:30 AM ET
| TSE:NRI | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | -- | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | -- | |
| LT Debt/Equity | -- | |
| Earnings Yield | -- | |
| Price/Sales | -- |
| Company | Last | Change |
|---|
Data is delayed by at least 15 min.